✓ Platba kartou obnovena — bezpečné platby přes Privacy Shield

Alzil

Alzil (Donepezil 5/10 mg) — Intas Pharma cholinesterase inhibitor for mild, moderate, and severe Alzheimer’s disease and dementia in Parkinson’s. Once-daily at bedtime. Modest symptomatic benefit.

Lékařsky ověřeno Morgan Ellis — Pharmacy Researcher · 8 years experience Last reviewed: May 2026

Šifrovaný nákup
Platba kryptoměnou - sleva 10%
Diskrétní doručení po celém světě
1 400+ zákazníků · 50+ zemí

Tento produkt je momentálně vyprodaný a nedostupný.

Rychlá odpověď

Alzil — donepezil 5/10 mg (Intas Pharma). Reversible centrally-acting acetylcholinesterase inhibitor for mild, moderate, and severe Alzheimer’s disease and dementia in Parkinson’s. Modest symptomatic improvement in cognition and ADLs; does not slow disease progression.

Co získáte s MedsBase:

  • výrobce certifikovaného WHO-GMP
  • Diskrétní balení v obyčejné obálce
  • Dodání po celém světě
  • Hodnoceno více než 1 400 zákazníky (číst recenze)

📦 Záruka opětovného zaslání: pokud vaše objednávka nedorazí do 20 pracovních dnů od odeslání, zašleme ji znovu bez dalších nákladů. Přečíst podmínky.

Proč objednávat z MedsBase

Alzil ships from a WHO-GMP certified manufacturer in plain packaging, billed through a regulated payment processor (the statement descriptor reads a regulated card-payment processor — never MedsBase or any medication name). Every order carries our 20-business-day Reshipment Assurance.

Set realistic expectations
Donepezil produces a modest, short-lived improvement in cognition (typically 2-4 points on the ADAS-cog) and may delay nursing-home placement. It does NOT slow underlying neurodegeneration. Effect plateaus and benefits may wear off over 6-24 months. Discuss realistic goals with the family before starting.

Dávkování

IndikaceDávka
Mild-moderate Alzheimer’s5 mg at bedtime × 4 weeks → 10 mg at bedtime
Severe Alzheimer’s10 mg/day; some clinicians titrate to 23 mg/day (where available)
Parkinson’s dementia / DLB5-10 mg/day at bedtime

Take in the evening with or without food. The 23 mg formulation must be swallowed whole; the 5/10 mg tablets can be crushed if needed.

Vedlejší účinky

  • Cholinergic GI (most common, dose-related): nausea, vomiting, diarrhoea, anorexia, weight loss
  • CNS: insomnia (try morning dosing if persistent), vivid dreams, dizziness, fatigue
  • Cardiac: bradycardia, syncope, AV block — caution with sick-sinus syndrome or pre-existing conduction defects; avoid combining with non-DHP CCBs or beta blockers without monitoring
  • Další: urinary incontinence (rare), seizure threshold lowering, NSAID-augmented GI bleed

Interakce léků

  • Strong anticholinergics: oxybutynin, hyoscine, TCAs, first-gen antihistamines — directly antagonise donepezil; avoid combining if possible
  • Bradycardic drugs: beta blockers, non-DHP CCBs (verapamil/diltiazem), digoxin — increased bradycardia/AV block risk; monitor
  • NSAIDs: increased GI bleed risk
  • CYP2D6 + CYP3A4 inhibitors: ketoconazole, paroxetine, fluoxetine — modest rise in donepezil levels; usually clinically insignificant
  • Succinylcholine (anaesthesia): prolonged neuromuscular block — tell the anaesthetist about donepezil use before any surgery

Často kladené dotazy

How quickly will I see improvement?

Cognitive and behavioural benefits, when they appear, are typically modest and emerge over 6-12 weeks. Some patients show no measurable benefit; this is expected and not a treatment failure.

When should it be stopped?

Stop if there is no perceived benefit after 3-6 months at the maximum tolerated dose, or if side effects (especially weight loss) outweigh benefit. Some clinicians continue into late-stage disease — the evidence is mixed.

Can it be combined with memantine?

Yes — combination therapy (donepezil + memantine) is approved and commonly used in moderate-to-severe disease. Memantine targets glutamate (NMDA) receptors, donepezil targets acetylcholine — different mechanisms, additive benefit, no major drug interactions.

Insomnia?

Donepezil can cause vivid dreams and insomnia. If persistent, switch to morning dosing.

Will it slow Alzheimer’s?

No. It is a symptomatic treatment. Underlying neurodegeneration continues. Newer disease-modifying agents (lecanemab, donanemab) do reduce amyloid plaques but are separate, expensive, infusion-based therapies with their own risks.

What about bradycardia?

Get a baseline ECG before starting if you have known heart conduction issues, are on beta blockers, or have unexplained syncope. Donepezil enhances vagal tone and rarely causes AV block.

Can my partner stop using anticholinergic OAB drugs?

If your loved one is on donepezil for Alzheimer’s, anticholinergic OAB drugs (oxybutynin, tolterodine) directly oppose the donepezil effect AND independently worsen cognition. Mirabegron (beta-3 agonist) is preferred for OAB in dementia patients.

Co když vynecháte dávku?

Skip the missed dose and resume the normal schedule. Do not double up. If multiple doses (more than a few days) are missed, restart at the lower 5 mg dose to avoid GI side effects.

Můžu pít alkohol?

Modest alcohol is acceptable. Heavy alcohol worsens cognitive decline independently of donepezil and should be discouraged.

Surgery and anaesthesia?

Tell the anaesthetist about donepezil — it prolongs the action of succinylcholine and other neuromuscular blockers. Some surgeons prefer to pause donepezil 24-48 hours before elective surgery; do this only on specialist advice.

Other Alzheimer’s & Dementia Medications

  • Nemdaa — memantine 5/10 mg — NMDA antagonist for moderate-severe disease
  • Donamem — donepezil + memantine fixed combo
  • Alzil — donepezil 5/10 mg — alternative brand
  • Donecept — donepezil 5/10 mg — Cipla brand
  • Donep — donepezil 5/10 mg — Alkem brand
Zdravotní upozornění: Tato stránka slouží pouze pro informaci a nenahrazuje lékařskou péči kvalifikovaného odborníka. Proberte jakékoli nové léky se svým lékařem nebo lékárníkem.

More options in Alzheimer's Treatment

Řazeno podle nedávného objemu objednávek na MedsBase — co si ostatní zákazníci v této kategorii vybírají.

Síla

Xarelto 20

Množství

30 tablet, 60 tablet, 90 tablet

Léková forma

Tablet/s

Výrobce

Intas Pharma

Léčba

Alzheimer's disease, Dementia in Parkinson's disease

Hodnocení

Zatím zde nejsou žádná hodnocení

Přidat hodnocení
Alzil Alzil
Hodnocení*
0/5
* Hodnocení je povinné
* Odpověď je povinná
Vaše hodnocení
* Hodnocení je povinné
Jméno
* Jméno je povinné
Přidejte fotografie nebo video k vašemu hodnocení

Otázky a odpovědi

Položit otázku
Alzil Alzil
Vaše otázka
* Otázka je povinná
Jméno
* Jméno je povinné
Zatím zde nejsou žádné dotazy